Nisa Investment Advisors LLC Grows Position in Procter & Gamble Company (The) $PG

Nisa Investment Advisors LLC grew its stake in Procter & Gamble Company (The) (NYSE:PG) by 5.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 644,807 shares of the company’s stock after buying an additional 31,743 shares during the quarter. Procter & Gamble makes up 0.4% of Nisa Investment Advisors LLC’s portfolio, making the stock its 28th biggest holding. Nisa Investment Advisors LLC’s holdings in Procter & Gamble were worth $99,075,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Nova Wealth Management Inc. bought a new position in shares of Procter & Gamble in the first quarter worth approximately $26,000. Halbert Hargrove Global Advisors LLC bought a new stake in shares of Procter & Gamble during the 3rd quarter valued at $25,000. Signature Resources Capital Management LLC lifted its stake in shares of Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after buying an additional 72 shares in the last quarter. Mid American Wealth Advisory Group Inc. bought a new position in Procter & Gamble in the 2nd quarter worth $34,000. Finally, RMG Wealth Management LLC purchased a new stake in Procter & Gamble in the 2nd quarter worth $37,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Up 2.6%

Shares of NYSE PG opened at $141.57 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.46. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $179.99. The firm’s 50-day moving average price is $145.11 and its 200-day moving average price is $151.70. The stock has a market capitalization of $330.81 billion, a price-to-earnings ratio of 20.67, a P/E/G ratio of 4.65 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.09. The company had revenue of $22.39 billion for the quarter, compared to analysts’ expectations of $22.23 billion. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. On average, equities research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Friday, October 24th were paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend was Friday, October 24th. Procter & Gamble’s payout ratio is presently 61.75%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on PG. Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, December 29th. Cowen reissued a “buy” rating on shares of Procter & Gamble in a report on Thursday. JPMorgan Chase & Co. dropped their price target on Procter & Gamble from $165.00 to $157.00 and set a “neutral” rating for the company in a research note on Thursday, December 18th. TD Cowen reduced their price objective on shares of Procter & Gamble from $168.00 to $150.00 and set a “buy” rating on the stock in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of Procter & Gamble from $176.00 to $171.00 and set a “buy” rating for the company in a research note on Monday, December 8th. Fifteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $169.23.

Insiders Place Their Bets

In other news, CAO Matthew W. Janzaruk sold 725 shares of the stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total value of $108,438.25. Following the sale, the chief accounting officer owned 979 shares of the company’s stock, valued at approximately $146,429.03. This represents a 42.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.20% of the stock is owned by company insiders.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G’s pricing power and margin resilience are highlighted in sector write-ups that include PG as a defensive name, supporting upside and dividend reliability. 5 Under-the-Radar Consumer Staples Stocks With Pricing Power (PG)
• Positive Sentiment: Analyst and commentary pieces note operational focus under new leadership (pricing, cost discipline) that could drive margin improvement over time. Procter & Gamble: Intense Focus Makes It Attractive
• Neutral Sentiment: P&G agreed to change Crest kids’ toothpaste packaging and marketing after the Texas AG raised concerns — the move removes regulatory uncertainty but adds short-term remediation and reputational work. Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
• Neutral Sentiment: Coverage highlighting legal scrutiny alongside a new CEO focus on pricing frames a mixed narrative — potential for better pricing execution balanced against regulatory/legal headline risk. Should Legal Scrutiny And New CEO Focus On Pricing Shape Procter & Gamble’s (PG) Investment Narrative?
• Neutral Sentiment: Wells Fargo trimmed its price target (keeps Overweight), reflecting model resets across categories but maintaining a constructive stance — suggests upside remains but at lower conviction. Wells Fargo Trims Procter & Gamble (PG) Target as 2026 Models Reset
• Neutral Sentiment: TD Cowen (reported via market outlets) and other shops have lowered targets — analysts still often keep Buy/Overweight ratings, but trimmed targets compress near-term upside. Benzinga (TD Cowen target note)
• Negative Sentiment: Valuation-focused pieces argue PG trades above intrinsic value after recent gains; some analysts call it a Hold given modest topline growth outlook versus ~20x+ multiples. Procter & Gamble: A Wide Moat, Solid Business – And Still Not A Buy
• Negative Sentiment: The stock recently hit a 52-week low amid softer category demand and promotional pressure, signaling macro weakness in core markets that could weigh near-term results. Procter & Gamble Hits 52-Week Low: Buy Opportunity or Warning Sign?
• Negative Sentiment: Broker notes and headlines show growing short-term caution (extended losing sessions, peers upgraded while PG is watched), leaving the stock sensitive to execution and macro updates. Procter & Gamble extends losing streak for seventh straight session

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.